Domino N-H/C-H bond activation: palladium-catalyzed synthesis of annulated heterocycles using dichloro(hetero)arenes.

L. Ackermann,A. Althammer

DOI: https://doi.org/10.1002/ANIE.200603833

2007-02-26

Angewandte Chemie

Abstract:

What problem does this paper attempt to address?

A first passage model of intravitreal drug delivery and residence time, in relation to ocular geometry, individual variability, and injection location

Patricia Lamirande,Eamonn A. Gaffney,Michael Gertz,Philip K. Maini,Jessica R. Crawshaw,Antonello Caruso

2024-04-05

Abstract:Purpose: Standard of care for various retinal diseases involves recurrent intravitreal injections. This motivates mathematical modelling efforts to identify influential factors for drug residence time, aiming to minimise administration frequency. We sought to describe the vitreal diffusion of therapeutics in nonclinical species used during drug development assessments. In human eyes, we investigated the impact of variability in vitreous cavity size and eccentricity, and in injection location, on drug elimination.

Quantitative Methods,Analysis of PDEs
Models and Algorithms for the Refinement of Therapeutic Approaches for Retinal Diseases

Elfriede Friedmann,Simon Dörsam,Gerd U Auffarth

DOI: https://doi.org/10.3390/diagnostics13050975

2023-03-03

Abstract:We are developing a Virtual Eye for in silico therapies to accelerate research and drug development. In this paper, we present a model for drug distribution in the vitreous body that enables personalized therapy in ophthalmology. The standard treatment for age-related macular degeneration is anti-vascular endothelial growth factor (VEGF) drugs administered by repeated injections. The treatment is risky, unpopular with patients, and some of them are unresponsive with no alternative treatment. Much attention is paid to the efficacy of these drugs, and many efforts are being made to improve them. We are designing a mathematical model and performing long-term three-dimensional Finite Element simulations for drug distribution in the human eye to gain new insights in the underlying processes using computational experiments. The underlying model consists of a time-dependent convection-diffusion equation for the drug coupled with a steady-state Darcy equation describing the flow of aqueous humor through the vitreous medium. The influence of collagen fibers in the vitreous on drug distribution is included by anisotropic diffusion and the gravity via an additional transport term. The resulting coupled model was solved in a decoupled way: first the Darcy equation with mixed finite elements, then the convection-diffusion equation with trilinear Lagrange elements. Krylov subspace methods are used to solve the resulting algebraic system. To cope with the large time steps resulting from the simulations over 30 days (operation time of 1 anti-VEGF injection), we apply the strong A-stable fractional step theta scheme. Using this strategy, we compute a good approximation to the solution that converges quadratically in both time and space. The developed simulations were used for the therapy optimization, for which specific output functionals are evaluated. We show that the effect of gravity on drug distribution is negligible, that the optimal pair of injection angles is (50∘,50∘), that larger angles can result in 38% less drug at the macula, and that in the best case only 40% of the drug reaches the macula while the rest escapes, e.g., through the retina, that by using heavier drug molecules, more of the drug concentration reaches the macula in an average of 30 days. As a refined therapy, we have found that for longer-acting drugs, the injection should be made in the center of the vitreous, and for more intensive initial treatment, the drug should be injected even closer to the macula. In this way, we can perform accurate and efficient treatment testing, calculate the optimal injection position, perform drug comparison, and quantify the effectiveness of the therapy using the developed functionals. We describe the first steps towards virtual exploration and improvement of therapy for retinal diseases such as age-related macular degeneration.
Computational modeling of intraocular drug delivery supplied by porous implants

Seyedalireza Abootorabi,Abhimanyu Tripathi,Huidan Whitney Yu,Lilian P. Dávila

DOI: https://doi.org/10.1007/s13346-020-00878-2

2021-01-11

Drug Delivery and Translational Research

Abstract:New and efficient drug delivery to the posterior part of the eye is a growing health necessity worldwide. Current treatment of eye diseases, such as age-related macular degeneration (AMD), relies on repeated intravitreal injections of drug-containing solutions. Such a drug delivery has major drawbacks including short drug life, significant medical service, and high medical cost. In this study, we explored a new approach to controlled drug delivery by introducing unique porous implants. Our computational modeling contained key physiological and anatomical traits. Incompressible flow in a porous media field, including the sclera, choroid, and retina layers, is governed by Darcy law and the time evolution of the drug concentration was solved via three convection–diffusion equations in the three layers, respectively. The computational model was validated by established results from independent studies and experimental data. Simulations of the IgG1 Fab drug delivery to the posterior eye were performed to evaluate the effectiveness of the porous implants for controlled delivery. Overall, our results indicate that drug therapeutic levels in the posterior eye sustain for eight weeks similarly to those using intravitreal injection. We first evaluated the effects of the porous implants on the drug delivery in the posterior layers. Subsequent simulations were carried out with varying porosity values in a porous episcleral implant. We found that the time evolution of drug concentration is distinctively correlated to drug source location and pore size. A correlation between porosity and fluid properties for selected porous implants was revealed for the first time in this study.

pharmacology & pharmacy,medicine, research & experimental
{Computer Modeling of Bevacizumab Drug Distribution after Intravitreal Injection in Rabbit and Human Eyes}

Jabia M. Chowdhury,Eduardo A. Chacin Ruiz,Matthew P. Ohr,Katelyn E. Swindle-Reilly,Ashlee N. Ford Versypt

DOI: https://doi.org/10.1101/2023.05.05.539491

2024-08-10

Abstract:Age-related macular degeneration (AMD) is a progressive eye disease that causes loss of central vision and has no cure. Wet AMD is the late neovascular form treated with vascular endothelial growth factor (VEGF) inhibitors. VEGF is the critical driver of wet AMD. One common off-label anti-VEGF drug used in AMD treatment is bevacizumab. Experimental efforts have been made to investigate the pharmacokinetic (PK) behavior of bevacizumab in vitreous and aqueous humor. Still, the quantitative effect of elimination routes and drug concentration in the macula are not well understood. In this work, we developed two spatial models representing rabbit and human vitreous to better understand the PK behavior of bevacizumab. This study explores different cases of drug elimination and the effects of injection location on drug concentration profiles. The models are validated by comparing them with experimental data. Our results suggest that anterior elimination is dominant for bevacizumab clearance from rabbit vitreous, whereas both anterior and posterior elimination have similar importance in drug clearance from the human vitreous. Furthermore, results indicate that drug injections closer to the posterior segment of the vitreous help maintain relevant drug concentrations for longer, improving bevacizumab duration of action at the fovea, which is located at the center of the macula. The rabbit and human models predict bevacizumab concentration in the vitreous and fovea, enhancing knowledge and understanding of wet AMD treatment.

Systems Biology
Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products

Carrie German,Zhijian Chen,Andrzej Przekwas,Ross Walenga,Andrew Babiskin,Liang Zhao,Jianghong Fan,Ming-Liang Tan

DOI: https://doi.org/10.1007/s11095-023-03480-6

Abstract:Introduction: Although the eye is directly accessible on the surface of the human body, drug delivery can be extremely challenging due to the presence of multiple protective barriers in eye tissues. Researchers have developed complex formulation strategies to overcome these barriers to ophthalmic drug delivery. Current development strategies rely heavily on in vitro experiments and animal testing to predict human pharmacokinetics (PK) and pharmacodynamics (PD). Objective: The primary objective of the study was to develop a high-fidelity PK/PD model of the anterior eye for topical application of ophthalmic drug products. Methods: Here, we present a physiologically-based in silico approach to predicting PK and PD in rabbits after topical administration of ophthalmic products. A first-principles based approach was used to describe timolol dissolution, transport, and distribution, including consideration of ionized transport, following topical instillation of a timolol suspension. Results: Using literature transport and response parameters, the computational model described well the concentration-time and response-time profiles in rabbit. Comparison of validated rabbit model results and extrapolated human model results demonstrate observable differences in the distribution of timolol at multiple time points. Conclusion: This modeling framework provides a tool for model-based prediction of PK in eye tissues and PD after topical ophthalmic drug administration to the eyes.
Ring-like fat deposition in the spinal arteries and its predilection sites [proceedings].

I. Akiguchi,R. Horie,Y. Yamori,K. Ohta,A. Ooshima,Y. Nara,M. Ohtaka,M. Kameyama

DOI: https://doi.org/10.1536/IHJ.20.691

1979-09-01

Japanese Heart Journal

Abstract:
A Physiology-Based Mathematical Model to Understand Drug Delivery from Contact Lenses to the Back of the Eye

Nadia Toffoletto,Benilde Saramago,Ana Paula Serro,Anuj Chauhan

DOI: https://doi.org/10.1007/s11095-023-03560-7

Abstract:Objective: Therapeutic contact lenses, able to store drug and deliver it to the eye surface in a sustained fashion, gained interest as an effective and patient-friendly alternative to eye drops. Recent animal studies also demonstrated the presence of therapeutic drug levels in the back of the eye after wearing drug-loaded contact lenses, thus opening the possibility of treating the posterior segment without need of invasive intraocular injections. The drug pathways from contact lenses to the back of the eye require further investigation. Methods: A mechanistic mathematical model was developed to evaluate the drug concentration over time in the tears, sclera and choroid, retina, aqueous humor and vitreous humor after the application of a therapeutic contact lens. The main drug transport mechanisms of the eye and the barrier properties of the different tissues were included in the model. Validation was performed by comparison with experimental data in literature. Results: The model predictions of drug concentration over time reflected the experimental data both in the anterior and posterior segment of the eye. The model can differentiate between contributions to transport from different pathways. Conclusions: The model constitutes a first step towards the possibility of predicting the ocular drug distribution and the treatment efficacy in the early stage of contact lens development, and it may help reduce both the need for in vivo tests (with ethical and economic advantages) and the gap between the lens design and clinical application. It also allows for an improved understanding of drug transport in the eye.
Scale effects in ballistic wounding.

B. Janzon,B. Schantz,T. Seeman

DOI: https://doi.org/10.1097/00005373-198801001-00008

Abstract:
Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes

Hyeong Min Kim,Seungmin Ha,Hye Kyoung Hong,Yoonha Hwang,Pilhan Kim,Eunsol Yang,Jae Yong Chung,Sunyoung Park,Young Joo Park,Kyu Hyung Park,Hyuncheol Kim,Joon Woo,Se Joon Woo

DOI: https://doi.org/10.1167/tvst.9.6.20

2020-05-20

Abstract:Purpose: To investigate the intraocular distribution and kinetics of antibodies and nanoparticles in the experimental model.Methods: Antibodies (whole IgG 149kDa, antigen-binding fragments 48.39 kDa) and four kinds of nondegradable nanoparticles (25, 50, 200, and 250 nm) were intravitreally injected in the right eye of New Zealand white rabbits. The average optical density and concentration were used to measure intraocular distribution and kinetics.Results: After intravitreal injection, antibodies were distributed throughout the vitreous humor and eliminated gradually into anterior and posterior routes. Fluorescence intensity decreased 1 day after injection and was not detected 25 days after injection. The nondegradable nanoparticles migrated posteriorly to the retina 7 days after injection onward and anteriorly to the aqueous humor from 1 hour to 1 day after injection. The fluorescence intensity of the nanoparticles was relatively stable in the vitreous humor, compared to antibodies. Nanoparticles accumulated on the internal limiting membrane of the retina with no penetration into deeper retinal tissue, whereas the smaller size 25 nm nanoparticles passed across the ciliary body and moved into choroid, retina, and suprachoroidal space. A gradual decrease of nanoparticles by their sizes in the vitreous after 30 days after injection was described as the percentage ratio: 61.1% (25 nm), 69.1% (50 nm), 78.6% (200nm), and 85.3% (250 nm).Conclusions: Our study revealed the in vivo intraocular distribution and kinetics of antibodies and nanoparticles with diverse sizes and the result might help to develop newer intraocular drugs and drug delivery systems to treat retinal diseases.Translational Relevance: These experimental results can be valuable data for human research.

ophthalmology
Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System

Emily Dosmar,Gabrielle Vuotto,Xingqi Su,Emily Roberts,Abigail Lannoy,Garet J. Bailey,William F. Mieler,Jennifer J. Kang-Mieler

DOI: https://doi.org/10.3390/pharmaceutics13111862

IF: 6.525

2021-11-04

Pharmaceutics

Abstract:The purpose of this study was to examine antibiotic drug transport from a hydrogel drug delivery system (DDS) using a computational model and a 3D model of the eye. Hydrogel DDSs loaded with vancomycin (VAN) were synthesized and release behavior was characterized in vitro. Four different compartmental and four COMSOL models of the eye were developed to describe transport into the vitreous originating from a DDS placed topically, in the subconjunctiva, subretinally, and intravitreally. The concentration of the simulated DDS was assumed to be the initial concentration of the hydrogel DDS. The simulation was executed over 1500 and 100 h for the compartmental and COMSOL models, respectively. Based on the MATLAB model, topical, subconjunctival, subretinal and vitreous administration took most (~500 h to least (0 h) amount of time to reach peak concentrations in the vitreous, respectively. All routes successfully achieved therapeutic levels of drug (0.007 mg/mL) in the vitreous. These models predict the relative build-up of drug in the vitreous following DDS administration in four different points of origin in the eye. Our model may eventually be used to explore the minimum loading dose of drug required in our DDS leading to reduced drug use and waste.

pharmacology & pharmacy
Drug Delivery from a Ring Implant Attached to Intraocular Lens: An in-silico Investigation

Pawan Kumar Pandey,Manish Jain,Prateek K Jha

DOI: https://doi.org/10.1016/j.xphs.2024.09.001

2024-09-06

Abstract:Multiple iterations required to design ocular implants, which will last for the desired operational period of months or even years, necessitate the use of in-silico models for ocular drug delivery. In this study, we developed an in-silico model to simulate the flow of Aqueous Humor (AH) and drug delivery from an implant to the Trabecular Meshwork (TM). The implant, attached to the side of the intraocular lens (IOL), and the TM are treated as porous media, with their effects on AH flow accounted for using the Darcy equation. This model accurately predicts the physiological values of Intraocular Pressure (IOP) for both healthy individuals and glaucoma patients, as reported in the literature. Results reveal that the effective diffusivity of the drug within the implant is the critical parameter that can alter the bioavailability time period (BTP) from a few days to months. Intuitively, BTP should increase as effective diffusivity decreases. However, we discovered that with lower levels of initial drug loading, BTP declines when effective diffusivity falls below a specific threshold. Our findings further reveal that, while AH flow has a minimal effect on the drug release profile at the implant site, it significantly impacts drug availability at the TM.
Role of centrifugal pathways to cochlear nucleus in determination of critical bandwidth.

J. Pickles

DOI: https://doi.org/10.1152/JN.1976.39.2.394

1976-03-01

Journal of Neurophysiology

Abstract:Atropine sulfate was applied locally to the cochlear nucleus of three unanesthetized cats in order to block the cholinergic centrifugal innervation of the nucleus. The critical bandwidth was measured behaviorally from the masked thresholds of 1-kHz tone pips in different bandwidths of masking noise. Atropine increased the critical bandwidth markedly. This suggests that normally the centrifugal pathways influence the critical bandwidth. Saline solutions alone had no effect, and if the cannula was not accurately implanted over the cochlear nucleus, atropine had no effect either.
Mathematical Model of Macromolecular Drug Transport in a Partially Liquefied Vitreous Humor

Anahid Khoobyar,Anita N Penkova,Mark S Humayun,Satwindar Singh Sadhal

DOI: https://doi.org/10.1115/1.4053197

2022-03-01

Abstract:The purpose of this study is to investigate the effect of partial liquefaction (due to ageing) of the vitreous humor on the transport of ocular drugs. In our model, the gel part of the vitreous is treated as a Darcy-type porous medium. A spherical region within the porous part of vitreous is in a liquid state which, for computational purposes, is also treated as a porous medium but with a much higher permeability. Using the finite element method, a time-dependent, three-dimensional model has been developed to computationally simulate (using the Petrov-Galerkin method) the transport of intravitreally injected macromolecules where both convection and diffusion are present. From a fluid physics and transport phenomena perspective, the results show many interesting features. For pressure-driven flow across the vitreous, the flow streamlines converge into the liquefied region as the flow seeks the fastest path of travel. Furthermore, as expected, with increased level of liquefaction, the overall flow rate increases for a given pressure drop. We have quantified this effect for various geometrical considerations. The flow convergence into the liquefied region has important implication for convective transport. One effect is the clear diversion of the drug as it reaches the liquefied region. In some instances, the entry point of the drug in the retinal region gets slightly shifted due to liquefaction. While the model has many approximations and assumptions, the focus is illustrating the effect of liquefaction as one of the building blocks toward a fully comprehensive model.
Interfacial behavior of intravitreally injected drugs simulated by models of the silicone oil filled eye

Anfisa Ayalon,Alexander Rubowitz,Pritam Kumar Roy,Shraga Shoval,Irina Legchenkova,Edward Bormashenko

DOI: https://doi.org/10.1680/jsuin.22.01011

IF: 2.397

2022-06-02

Surface Innovations

Abstract:The paper is devoted to the interfacial aspects of the intraocular behavior, migration and distribution of commonly injected ophthalmic drugs in eyes filled with medical-grade 1300 cSt silicone oil used as a retinal tamponade agent. Novel in vitro and ex vivo models were created for studying the physical properties of the retinal surface and interfacial spreading of the ophthalmic drugs over retinas. In vitro model experiments showed that droplets of all tested drugs sank rapidly in the silicone oil to contact with the plasma-treated glass, and then rapidly spread over the glass surface. In the ex vivo model, the migration phase was followed by contact with, and rapid spread/absorption by the retinal interface. The wetting behavior of drugs under contact with the glass substrate and retinas was similar. Characteristic time scales of drugs spreading, controlled by the viscous dissipation, were close. All tested drugs migrated to the retinal surface and rapidly spread across the retinal surface. This suggests that intravitreal drugs might be used effectively in eyes filled with a silicone oil tamponade, as they rapidly migrate to, and spread over the retinal surface.

chemistry, physical,materials science, coatings & films
Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model

Sulabh Patel,Gerd Müller,Jan Olaf Stracke,Ulrike Altenburger,Hanns-Christian Mahler,Dhananjay Jere

DOI: https://doi.org/10.1016/j.ejpb.2015.04.033

IF: 5.589

2015-09-01

European Journal of Pharmaceutics and Biopharmaceutics

Abstract:The stability of protein therapeutics during the residence time in the vitreous humor (VH) is an important consideration for intra ocular treatment and can possibly impact therapeutic efficacy and/or treatment intervals. Unavailability of the reliable Ex-vivo intravitreal (ExVit) model to estimate protein stability following IVT has driven the research focus to develop such model which can facilitate protein stability estimation before in-vivo experiments. In this manuscript, we have developed and evaluated three ExVit models, namely, ExVit static, semi-dynamic and dynamic. These models were utilized and compared when studying the in-vitro stability of model protein formulations under simulated intraocular conditions using porcine vitreous humor (VH). The ExVit static model exhibited significant precipitation and aggregation of proteins, most likely due to pH change occurred in the VH after isolation. The semi-dynamic model assessed was composed of two compartments i.e., VH- and buffer-compartment which has effectively stabilized the pH of the VH and facilitated the migration of VH degradation products. However, some limitations related to investigation of long-term protein stability were also observed with semi-dynamic model. The dynamic model developed, was comprised of three diffusion controlling barriers (two diffusion controlling membranes and a gel-matrix), which allowed modulation of the diffusion rate of macromolecules. The ability of dynamic model to modulate protein retention time in the VH will overcome the challenges faced by the semi-dynamic model such as long-term stability evaluation.

pharmacology & pharmacy
A comprehensive insight on ocular pharmacokinetics

Vibhuti Agrahari,Abhirup Mandal,Vivek Agrahari,Hoang M. Trinh,Mary Joseph,Animikh Ray,Hicheme Hadji,Ranjana Mitra,Dhananjay Pal,Ashim K. Mitra

DOI: https://doi.org/10.1007/s13346-016-0339-2

2016-10-31

Drug Delivery and Translational Research

Abstract:The eye is a distinctive organ with protective anatomy and physiology. Several pharmacokinetics compartment models of ocular drug delivery have been developed for describing the absorption, distribution, and elimination of ocular drugs in the eye. Determining pharmacokinetics parameters in ocular tissues is a major challenge because of the complex anatomy and dynamic physiological barrier of the eye. In this review, pharmacokinetics of these compartments exploring different drugs, delivery systems, and routes of administration is discussed including factors affecting intraocular bioavailability. Factors such as precorneal fluid drainage, drug binding to tear proteins, systemic drug absorption, corneal factors, melanin binding, and drug metabolism render ocular delivery challenging and are elaborated in this manuscript. Several compartment models are discussed; these are developed in ocular drug delivery to study the pharmacokinetics parameters. There are several transporters present in both anterior and posterior segments of the eye which play a significant role in ocular pharmacokinetics and are summarized briefly. Moreover, several ocular pharmacokinetics animal models and relevant studies are reviewed and discussed in addition to the pharmacokinetics of various ocular formulations.

pharmacology & pharmacy,medicine, research & experimental
Ocular Drug Delivery: Present Innovations and Future Challenges

Vrinda Gote,Sadia Sikder,Jeff Sicotte,Dhananjay Pal

DOI: https://doi.org/10.1124/jpet.119.256933

2019-05-09

Journal of Pharmacology and Experimental Therapeutics

Abstract:Ocular drug delivery has always been a challenge for ophthalmologists and drug-delivery scientists due to the presence of various anatomic and physiologic barriers. Inimitable static and dynamic ocular barriers not only exclude the entry of xenobiotics but also discourage the active absorption of therapeutic agents. Designing an ideal delivery scheme should include enhanced drug bioavailability and controlled release of drug at the site of action, which can overcome various ocular barriers. Conventional ophthalmic medications include the use of topical eye drops and intravitreal injections of anti–vascular endothelial growth factor agent for treatment of anterior and posterior segment disorders, respectively. Current inventions for anterior ocular segment disorders such as punctum plugs, ocular implants, drug-eluting contact lenses, and ocular iontophoresis represent state-of-the-art inventions for sustained and controlled drug release. Parallel efforts for ocular drug delivery technologies for back of the eye disorders have resulted in the approval of various intravitreal implants. Novel drug-delivery technologies, including nanoparticles, nanomicelles, dendrimers, microneedles, liposomes, and nanowafers, are increasingly studied for anterior and posterior disorders. To achieve patient compliance for back of the eye disorders, novel approaches for noninvasive delivery of potent therapeutic agents are on the rise. In this review article, we discuss past successes, present inventions, and future challenges in ocular drug-delivery technologies. This expert opinion also discusses the future challenges for ocular drug-delivery systems and the clinical translatable potential of nanotechnology from benchtop to bedside.

pharmacology & pharmacy
Pharmacokinetic aspects of retinal drug delivery

Eva M. del Amo,Anna-Kaisa Rimpelä,Emma Heikkinen,Otto K. Kari,Eva Ramsay,Tatu Lajunen,Mechthild Schmitt,Laura Pelkonen,Madhushree Bhattacharya,Dominique Richardson,Astrid Subrizi,Tiina Turunen,Mika Reinisalo,Jaakko Itkonen,Elisa Toropainen,Marco Casteleijn,Heidi Kidron,Maxim Antopolsky,Kati-Sisko Vellonen,Marika Ruponen,Arto Urtti

DOI: https://doi.org/10.1016/j.preteyeres.2016.12.001

IF: 19.704

2017-03-01

Progress in Retinal and Eye Research

Abstract:Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.

ophthalmology
An Intravitreal Implant Injection Method for Sustained Drug Delivery into Mouse Eyes

Young Joo Sun,Cheng-Hui Lin,Man-Ru Wu,Soo Hyeon Lee,Jing Yang,Caitlin R. Kunchur,Elena M. Mujica,Bryce Chiang,Youn Soo Jung,Sui Wang,Vinit B. Mahajan

DOI: https://doi.org/10.1016/j.crmeth.2021.100125

2021-01-01

Cell Reports Methods

Abstract:Using small molecule drugs to treat eye diseases carries benefits of specificity, scalability, and transportability, but their efficacy is significantly limited by a fast intraocular clearance rate. Ocular drug implants (ODIs) present a compelling means for the slow and sustained release of small molecule drugs inside the eye. However, methods are needed to inject small molecule ODIs into animals with small eyes, such as mice, which are the primary genetic models for most human ocular diseases. Consequently, it has not been possible to fully investigate efficacy and ocular pharmacokinetics of ODIs. Here, we present a robust, cost-effective, and minimally invasive method called "mouse implant intravitreal injection" (MI3) to deliver ODIs into mouse eyes. This method will expand ODI research to cover the breadth of human eye diseases modeled in mice.
A Computational Fluid Dynamics study of drug-releasing ocular implants for glaucoma treatment: Comparison of implant size and locations

Elisa Molla,Tao Chen,Cynthia Yu-Wai-Man,Daniel Sebastia-Saez

2024-10-02

Abstract:Drug-releasing implants are gaining momentum in the treatment of glaucoma. Implants present however several limitations. Among these limitations, there is the inability to provide an even distribution of the drug in the trabecular meshwork. CFD simulations were used in this work to study the interplay between ocular fluid dynamics and drug diffusion to explore the options to achieve a homogeneous drug distribution. The analysis finds that the balance between convection and diffusion flux hinders mixing within the eye's anterior chamber. This results in highly localized drug delivery in the trabecular meshwork when using a gravity-driven location implant. The results also show that varying the size of the implant can help to solve the issue. Given the natural variability of the trabecular meshwork size amongst patients, implants with personalized size may become a potential solution. The location of the implant within the eye is also key to effective drug delivery. Natural laminar flow of aqueous humor within the eye's anterior chamber prevents achieving an even drug distribution at the target tissue for gravity-driven location implants. However, the iris-lens gap can be utilized as a natural mixer when placing the implant in the eye's posterior chamber, thus helping with effective delivery.

Tissues and Organs

Domino N-H/C-H bond activation: palladium-catalyzed synthesis of annulated heterocycles using dichloro(hetero)arenes.

A first passage model of intravitreal drug delivery and residence time, in relation to ocular geometry, individual variability, and injection location

Models and Algorithms for the Refinement of Therapeutic Approaches for Retinal Diseases

Computational modeling of intraocular drug delivery supplied by porous implants

{Computer Modeling of Bevacizumab Drug Distribution after Intravitreal Injection in Rabbit and Human Eyes}

Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products

Ring-like fat deposition in the spinal arteries and its predilection sites [proceedings].

A Physiology-Based Mathematical Model to Understand Drug Delivery from Contact Lenses to the Back of the Eye

Scale effects in ballistic wounding.

Intraocular Distribution and Kinetics of Intravitreally Injected Antibodies and Nanoparticles in Rabbit Eyes

Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System

Drug Delivery from a Ring Implant Attached to Intraocular Lens: An in-silico Investigation

Role of centrifugal pathways to cochlear nucleus in determination of critical bandwidth.

Mathematical Model of Macromolecular Drug Transport in a Partially Liquefied Vitreous Humor

Interfacial behavior of intravitreally injected drugs simulated by models of the silicone oil filled eye

Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model

A comprehensive insight on ocular pharmacokinetics

Ocular Drug Delivery: Present Innovations and Future Challenges

Pharmacokinetic aspects of retinal drug delivery

An Intravitreal Implant Injection Method for Sustained Drug Delivery into Mouse Eyes

A Computational Fluid Dynamics study of drug-releasing ocular implants for glaucoma treatment: Comparison of implant size and locations